David LaGrand
David LaGrand | |
---|---|
Member of the Michigan House of Representatives from the 75th district | |
In office March 15, 2016 – January 1, 2023 | |
Preceded by | Brandon Dillon |
Succeeded by | Penelope Tsernoglou |
Personal details | |
Born | Grand Rapids, Michigan, US | August 13, 1966
Political party | Democratic |
Spouse | Melissa LaGrand |
Education | Calvin University (BA) University of Chicago School of Law (JD) |
Website | https://davidlagrand.com |
David LaGrand (born August 13, 1966) is an American politician who is served in the Michigan House of Representatives from the 75th district, from 2016 to 2023.[1][2] In 2022, he ran for election to the Michigan Senate in the 30th district, narrowly losing to incumbent Mark Huizenga. He resides in Grand Rapids, Michigan with his wife, Melissa LaGrand, and four children: John, Issac, Helen, and Julia.[3] As of 2023, he is running for the position of Mayor of Grand Rapids against City Commissioner Senita Lenear.
Early life and education
LaGrand is a graduate of the local Calvin College (now Calvin University) (1988) and the University of Chicago Law School (1992).[3]
Career
After graduating, David returned to Grand Rapids in 1994 and worked at local law firm Warner Norcross & Judd while founding a local coffee shop. He then served 8 years as an Assistant County Prosecutor in Kent County, Michigan, before forming private law firms Lykins & LaGrand PLC, and later Yates, LaGrand and Denenfeld PLLC. During this time, he founded another restaurant, Wealthy Street Bakery. He was then elected to the Grand Rapids City Commission, where he and partners started Long Road Distillers. In 2015, he ran and won election to the Michigan House of Representatives, where he currently serves.[3]
References
- ^ "David LaGrand wins Michigan House seat in special election". MLive.com. 2016-03-08. Retrieved 2019-02-19.
- ^ "News from Rep. LaGrand". housedems.com. Retrieved 2019-02-19.
- ^ a b c "Election | David LaGrand for State Senate | Grand Rapids". David LaGrand. Retrieved 2022-11-01.